These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2200737)

  • 1. Casein kinase II enhances the DNA binding activity of serum response factor.
    Manak JR; de Bisschop N; Kris RM; Prywes R
    Genes Dev; 1990 Jun; 4(6):955-67. PubMed ID: 2200737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression.
    Manak JR; Prywes R
    Oncogene; 1993 Mar; 8(3):703-11. PubMed ID: 8437853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase II phosphorylation increases the rate of serum response factor-binding site exchange.
    Marais RM; Hsuan JJ; McGuigan C; Wynne J; Treisman R
    EMBO J; 1992 Jan; 11(1):97-105. PubMed ID: 1740119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of serum response factor phosphorylation sites and the mechanism by which its DNA-binding activity is increased by casein kinase II.
    Manak JR; Prywes R
    Mol Cell Biol; 1991 Jul; 11(7):3652-9. PubMed ID: 2046671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase II induces c-fos expression via the serum response element pathway and p67SRF phosphorylation in living fibroblasts.
    Gauthier-Rouvière C; Basset M; Blanchard JM; Cavadore JC; Fernandez A; Lamb NJ
    EMBO J; 1991 Oct; 10(10):2921-30. PubMed ID: 1915270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a novel DNA-binding protein kinase CKII-like enzyme of Chironomus cells.
    Stigare J; Buddelmeijer N; Pigon A; Egyházi E
    Cell Mol Biol Res; 1994; 40(5-6):463-72. PubMed ID: 7735320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity.
    Rivera VM; Miranti CK; Misra RP; Ginty DD; Chen RH; Blenis J; Greenberg ME
    Mol Cell Biol; 1993 Oct; 13(10):6260-73. PubMed ID: 8413226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites.
    Liu SH; Ma JT; Yueh AY; Lees-Miller SP; Anderson CW; Ng SY
    J Biol Chem; 1993 Oct; 268(28):21147-54. PubMed ID: 8407951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal phosphorylation of the serum-response factor.
    Janknecht R; Ernst WH; Houthaeve T; Nordheim A
    Eur J Biochem; 1993 Sep; 216(2):469-75. PubMed ID: 8375385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.
    Berberich SJ; Cole MD
    Genes Dev; 1992 Feb; 6(2):166-76. PubMed ID: 1737614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.
    Tresini M; Lorenzini A; Frisoni L; Allen RG; Cristofalo VJ
    Exp Cell Res; 2001 Oct; 269(2):287-300. PubMed ID: 11570821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear import of serum response factor (SRF) requires a short amino-terminal nuclear localization sequence and is independent of the casein kinase II phosphorylation site.
    Rech J; Barlat I; Veyrune JL; Vie A; Blanchard JM
    J Cell Sci; 1994 Nov; 107 ( Pt 11)():3029-36. PubMed ID: 7699002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the C-proteins of HeLa cell hnRNP particles. Involvement of a casein kinase II-type enzyme.
    Holcomb ER; Friedman DL
    J Biol Chem; 1984 Jan; 259(1):31-40. PubMed ID: 6423627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA bending in the ternary nucleoprotein complex at the c-fos promoter.
    Sharrocks AD; Shore P
    Nucleic Acids Res; 1995 Jul; 23(13):2442-9. PubMed ID: 7630721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle CaMKII enriches in nuclei and phosphorylates myogenic factor SRF at multiple sites.
    Flück M; Booth FW; Waxham MN
    Biochem Biophys Res Commun; 2000 Apr; 270(2):488-94. PubMed ID: 10753652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point mutational analysis of the human c-fos serum response factor binding site.
    Leung S; Miyamoto NG
    Nucleic Acids Res; 1989 Feb; 17(3):1177-95. PubMed ID: 2493627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.
    Kolman JL; Taylor N; Marshak DR; Miller G
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10115-9. PubMed ID: 8234266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle Ca(2+)-independent kinase activity increases during either hypertrophy or running.
    Flück M; Waxham MN; Hamilton MT; Booth FW
    J Appl Physiol (1985); 2000 Jan; 88(1):352-8. PubMed ID: 10642401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multiple SRF N-terminal phosphorylation sites affecting DNA binding properties.
    Janknecht R; Hipskind RA; Houthaeve T; Nordheim A; Stunnenberg HG
    EMBO J; 1992 Mar; 11(3):1045-54. PubMed ID: 1547771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein kinase II phosphorylates Ser468 in the PEST domain of the Drosophila IkappaB homologue cactus.
    Packman LC; Kubota K; Parker J; Gay NJ
    FEBS Lett; 1997 Jan; 400(1):45-50. PubMed ID: 9000511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.